Calamos Advisors
ORMP icon

Calamos Advisors’s Oramed Pharmaceuticals ORMP Stock Holding History

Calamos Advisors’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-14,746
Closed -$177K – 1205
2022
Q4 		$177K Buy
+14,746
New +$115K ﹤0.01% 953
2022
Q2 		– Sell
-38,071
Closed -$330K – 1208
2022
Q1 		$330K Sell
38,071
-73,448
-66% -$752K ﹤0.01% 1102
2021
Q4 		$1.59M Sell
111,519
-20,626
-16% -$431K 0.01% 934
2021
Q3 		$2.91M Buy
+132,145
New +$2.25M 0.01% 726

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $155M AUM 129.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SIGI
Susquehanna International Group (Ireland) Dublin, Ireland $472M AUM 25.62% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return